Patents Assigned to Daniel Javitt
  • D-serine transport antagonist for treating psychosis
    Publication number: 20020183390
    Abstract: Method and composition for augmenting NMDA receptor mediated neurotransmission involving use of a D-serine transport inhibitor.
    Type: Application
    Filed: February 6, 2002
    Publication date: December 5, 2002
    Applicant: DR. DANIEL JAVITT
    Inventor: Daniel Javitt
  • Treatment of negative and cognitive symptoms of schizophrenia with D-serine
    Patent number: 6162827
    Abstract: The amino acid glycine in an administered amount of above 0.4 g/Kg/day is used for treating symptoms of psychosis and of schizophrenia.
    Type: Grant
    Filed: December 16, 1998
    Date of Patent: December 19, 2000
    Assignee: Daniel Javitt
    Inventor: Daniel C. Javitt